| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Autoimmunity/Diabetes Group (W.C., K.V.S., Q.-S.M., M.G., T.C.M., P.Z., T.L.D.), Robarts Research Institute, London, Ontario N6G 2V4, Canada; and the Department of Microbiology and Immunology (T.C.M., T.L.D.), University of Western Ontario, London, Ontario N6A 5C1, Canada
Address all correspondence and requests for reprints to: Dr. Terry L. Delovitch, Director, Autoimmunity/Diabetes Group, Robarts Research Institute, 1400 Western Road, London, Ontario N6G 2V4, Canada. E-mail: del{at}robarts.ca.
IGF-I regulates islet ß-cell growth, survival, and metabolism and protects against type 1 diabetes (T1D). However, the therapeutic efficacy of free IGF-I may be limited by its biological half-life in vivo. We investigated whether prolongation of its half-life as an IGF-I/IGF binding protein (IGFBP)-3 complex affords increased protection against T1D and whether this occurs by influencing T cell function and/or islet ß-cell growth and survival. Administration of IGF-I either alone or as an IGF-I/IGFBP-3 complex reduced the severity of insulitis and delayed the onset of T1D in nonobese diabetic mice, but IGF-I/IGFBP-3 was significantly more effective. Protection from T1D elicited by IGF-I/IGFBP-3 was mediated by up-regulated CCL4 and down-regulated CCL3 gene expression in pancreatic draining lymph nodes, activation of the phosphatidylinositol 3-kinase and Akt/protein kinase B signaling pathway of ß-cells, reduced ß-cell apoptosis, and stimulation of ß-cell replication. Reduced ß-cell apoptosis resulted from elevated Bcl-2 and Bcl-XL activity and diminished caspase-9 activity, indicating a novel role for a mitochondrial-dependent pathway of ß-cell death. Thus, IGF-I/IGFBP-3 affords more efficient protection from insulitis, ß-cell destruction, and T1D than IGF-I, and this complex may represent an efficacious therapeutic treatment for the prevention of T1D.
This article has been cited by other articles:
 |
|
 |
|
  C. Louvet, G. L. Szot, J. Lang, M. R. Lee, N. Martinier, G. Bollag, S. Zhu, A. Weiss, and J. A. Bluestone Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice PNAS, December 2, 2008; 105(48): 18895 - 18900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Robertson, Y. Lu, K. De Jesus, B. Li, Q. Su, P. K. Lund, and J.-L. Liu A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E928 - E938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. McDonald, R. M Williams, F. M Regan, R. K Semple, and D. B Dunger IGF-I treatment of insulin resistance Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S51 - S56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Frost and C. H. Lang Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass J Appl Physiol, July 1, 2007; 103(1): 378 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Meagher, G. Arreaza, A. Peters, C. A. Strathdee, P. A. Gilbert, Q.-S. Mi, P. Santamaria, G. A. Dekaban, and T. L. Delovitch CCL4 Protects From Type 1 Diabetes by Altering Islet {beta}-Cell-Targeted Inflammatory Responses Diabetes, March 1, 2007; 56(3): 809 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Di Noia, S. Van Driesche, F. Palmieri, L.-M. Yang, S. Quan, A. I. Goodman, and N. G. Abraham Heme Oxygenase-1 Enhances Renal Mitochondrial Transport Carriers and Cytochrome c Oxidase Activity in Experimental Diabetes J. Biol. Chem., June 9, 2006; 281(23): 15687 - 15693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, H. Chen, and P. N. Epstein Metallothionein and Catalase Sensitize to Diabetes in Nonobese Diabetic Mice: Reactive Oxygen Species May Have a Protective Role in Pancreatic {beta}-Cells Diabetes, June 1, 2006; 55(6): 1592 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Stiles, C. Kuralwalla-Martinez, W. Guo, C. Gregorian, Y. Wang, J. Tian, M. A. Magnuson, and H. Wu Selective Deletion of Pten in Pancreatic {beta} Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes. Mol. Cell. Biol., April 1, 2006; 26(7): 2772 - 2781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kooijman and A. Coppens Insulin-like growth factor-I stimulates IL-10 production in human T cells J. Leukoc. Biol., October 1, 2004; 76(4): 862 - 867. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
